+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Liquid Biopsy Market by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis - Impact of COVID-19, Initiatives, Funding, Major Deals, and Recent Developments - Forecast to 2028

  • ID: 5144804
  • Report
  • October 2021
  • Region: Global
  • 552 Pages
  • iGATE Research

FEATURED COMPANIES

  • ANGLE plc
  • Bio-Rad Laboratories, Inc
  • DiaCarta, Inc.
  • Freenome
  • Inivata
  • Myriad Genetics, Inc

The global liquid biopsy market is predicted to reach US$ 9.53 Billion by 2028. Liquid biopsy tests are executed to understand the molecular aspects of cancer across the healthcare and research settings, such as hospitals, physicians, pathological and research laboratories. Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures. The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.
     
The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years. Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.  


Impact of COVID-19 on Global Liquid Biopsy Market

The COVID-19 outbreak has become a global stress test. As the number of people infected with the virus continues to rise around the world, uncertainties about global economic growth increases. The COVID–19 disease has infected around 243 Million people worldwide. Globally the death toll has reached 4,937,666 according to the latest statistics from the Worldometers (as of October 21, 2021).  The number is still growing, and the duration of the pandemic is still difficult to predict. The reactions to the COVID–19 pandemic and its effects on societies and economies around the world cannot be understated. The COVID–19 global pandemic has restricted the growth rate of the liquid biopsy market to some extent during 2020-2021. However, many countries have taken strict measures to combat the coronavirus, such as mass vaccination program, social distancing, use of masks, etc. Hence, we expect that the physicians/surgeons will see an increase in influx of patients, hence driving the liquid biopsy market growth.  


Recent Developments

  • In July 2021, Biocept, Inc. was awarded a South Korean Patent for its Primer-Switch technology, which detects rare mutations in circulating tumor DNA (ctDNA) using real-time PCR and associated analysis methods.
  • In April 2021, Bio-Techne Corporation completed the acquisition of Asuragen, Inc.
  • In March 2021, Lucence announced a partnership with Waseda University in Japan to develop a novel high-speed liquid biopsy laser-based imaging platform for early cancer detection.   
  • In February 2021, Guardant Health, Inc. announced the availability of Guardant Reveal, the first blood-only liquid biopsy test for the detection of residual and recurrent disease from a simple blood draw.
  • In August 2020, Freenome announced an oversubscribed US$ 270 million Series C financing, bringing the company's total financing to over US$ 500 million since the company’s launch.
  • On May 26, 2020, NeoGenomics, Inc. announced that it has formed a strategic collaboration with Inivata to commercialize the InVisionFirst-Lung liquid biopsy test in the United States.
  • In November 2019, Lucence Diagnostics Pte Ltd, a genomic medicine company based in Singapore, raised US$ 20 Million in Series A funding.
  • In June 2019, Saga Diagnostics, a Lund, Sweden based company raised US$ 4.1 Million in a financing round from Hadean Ventures.

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

  • Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells (CTCs).
  • The circulating tumor DNA (ctDNA) is the 2nd largest segment of the liquid biopsy market.
  • The cell free DNA (cfDNA) is the third largest segment of the liquid biopsy market.
  • The extracellular vesicles (EVs) segment is the fastest growing segment during the forecast period.

Global Liquid Biopsy Market & Forecast - by Products 

  • The global liquid biopsy market, by product, is being dominated by Kits and Consumables.
  • The instruments segment is likely to witness highest growth in the global liquid biopsy market.
  • The services segment captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by Application

  • The global liquid biopsy market, by application, is being dominated by oncology application.
  • Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.
  • The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

  • On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.
  • Treatment monitoring captured second highest share of the liquid biopsy market in 2020, being followed by the early cancer screening application.
  • Recurrence monitoring captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by End User

  • In 2020, Reference laboratories captured largest share of the global liquid biopsy market.
  • Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2020, being followed by Academic and Research Centers.

Global Liquid Biopsy Market & Forecast - by Sample Type

  • Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.
  • The urine sample segment is anticipated to witness noticeable growth throughout the forecast period.

Liquid Biopsy Market & Forecast - Regional Analysis 

  • North America accounted for largest share of the global liquid biopsy market in 2020, followed by Asia Pacific.
  • In North America, United States accounted for largest share of the liquid biopsy market.
  • In Europe, Germany and France are the leading market for liquid biopsy.
  • Asia pacific is the fastest growing market for liquid biopsy.
  • In Asia Pacific, Japan and China are the leading market for liquid biopsy.
  • Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.

The report titled “Global Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Impact of COVID-19, Initiatives, Funding, Major Deals, 35 Company Profiles and Recent Developments - Forecast to 2028” provides a comprehensive assessment of the fast-evolving, high-growth Global Liquid Biopsy Market.  


This 552 Page report with 118 Figures and 7 Tables has been analyzed from 16 viewpoints: 


  1. Global Liquid Biopsy Market & Forecast (2016 - 2028)
  2. Impact of COVID-19 on Global Liquid Biopsy Market
  3. Global Liquid Biopsy Market Share & Forecast (2016 - 2028)
  4. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2016 - 2028)
  5. Global Liquid Biopsy Market & Forecast - by Product (2016 - 2028)
  6. Global Liquid Biopsy Market & Forecast - by Application (2016 - 2028)
  7. Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types (2016 - 2028)
  8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2016 - 2028)
  9. Global Liquid Biopsy Market & Forecast - by End User (2016 - 2028)
  10. Global Liquid Biopsy Market & Forecast - by Sample Type (2016 - 2028)
  11. Liquid Biopsy Market & Forecast - Regional Analysis (2016 - 2028)
  12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2016 - 2028)
  13. Liquid Biopsy Initiatives
  14. Liquid Biopsy Companies Financing Details 
  15. 35 Company Profiles – Recent Developments / Initiatives, Major Deals 
  16. Global Liquid Biopsy Market - Driving Factors & Challenges

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker 

  • Circulating Tumor Cells (CTCs)
  • Circulating Tumor DNA (ctDNA)
  • Cell-Free DNA (cfDNA)
  • Extracellular Vesicles (EVs)
  • Other Circulating Biomarkers

Global Liquid Biopsy Market & Forecast - by Product 

  • Kits and Consumables 
  • Instruments 
  • Services 

Global Liquid Biopsy Market & Forecast - by Application 

  • Oncology Application 
  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Gastrointestinal Cancer
  • Leukaemia
  • Others
  • Non-Cancer Application

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

  • Therapy Selection 
  • Treatment Monitoring 
  • Early Cancer Screening 
  • Recurrence Monitoring

Global Liquid Biopsy Market & Forecast - by End User

  • Reference Laboratories
  • Hospitals and Physician Laboratories
  • Academic and Research Centers
  • Other End Users

Global Liquid Biopsy Market & Forecast - by Sample Type

  • Blood Sample
  • Urine Sample
  • Other Fluids Sample

Liquid Biopsy Market & Forecast - Regional Analysis 

  • North America
    • United States
    • Canada

  • Asia Pacific
    • South Korea
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific

  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Rest of Europe

  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Egypt
    • Rest of Middle East & Africa

  • Latin America

Liquid Biopsy Market - Company Profiles, Recent Developments / Initiatives, Major Deals


  1. Personal Genome Diagnostics
  2. Guardant Health, Inc.
  3. Pathway Genomics (Now OME CARE)
  4. RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
  5. Cardiff Oncology (Previously Trovagene, Inc.)
  6. LungLife AI (Formerly Cynvenio Biosystems, Inc.)
  7. Biocept, Inc.
  8. ANGLE plc
  9. MDxHealth
  10. Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)
  11. Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
  12. Foundation Medicine, Inc
  13. Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
  14. Genomic Health (Now Part of Exact Sciences Corp)
  15. Myriad Genetics, Inc
  16. Thermo Fisher Scientific, Inc
  17. QIAGEN NV
  18. Bio-Rad Laboratories, Inc
  19. Menarini-Silicon Biosystems
  20. GRAIL
  21. NeoGenomics, Inc.
  22. DiaCarta, Inc.
  23. OncoCell MDx (Now Immunis.AI)
  24. C2i Genomics
  25. Biodesix
  26. Freenome
  27. Inivata
  28. CellMax Life
  29. Rarecyte Inc.
  30. Saga Diagnostics
  31. Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)
  32. Lucence Diagnostics Pte Ltd
  33. Karius, Inc.
  34. Clinical Genomics Technologies Pty Ltd (CG)
  35. Elypta

Data Sources

The publisher employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.


Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.


Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.


Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • ANGLE plc
  • Bio-Rad Laboratories, Inc
  • DiaCarta, Inc.
  • Freenome
  • Inivata
  • Myriad Genetics, Inc

1. Executive Summary


2. Impact of COVID-19 on Global Liquid Biopsy Market


3. Global Liquid Biopsy Market & Forecast (2016 - 2028) 


4. Global Liquid Biopsy Market Share & Forecast (2016 - 2028)
4.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
4.2 Global Liquid Biopsy Market Share & Forecast - by Product
4.3 Global Liquid Biopsy Market Share & Forecast - by Application
4.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
4.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
4.6 Global Liquid Biopsy Market Share & Forecast - by End User
4.7 Global Liquid Biopsy Market Share & Forecast - by Sample Type
4.8 Liquid Biopsy Market Share & Forecast - Regional Analysis
4.9 Liquid Biopsy Market Share & Forecast - Country Wise Analysis


5. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2016 - 2028) 
5.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
5.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
5.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
5.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
5.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast


6. Global Liquid Biopsy Market & Forecast - by Product (2016 - 2028) 
6.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
6.2 Global Liquid Biopsy - Instruments Market & Forecast
6.3 Global Liquid Biopsy - Services Market & Forecast


7. Global Liquid Biopsy Market & Forecast - by Application (2016 - 2028)
7.1 Global Liquid Biopsy - Oncology Application Market & Forecast
7.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
7.2.1 Lung Cancer Liquid Biopsy Market & Forecast
7.2.2 Breast Cancer Liquid Biopsy Market & Forecast
7.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
7.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
7.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
7.2.6 Leukaemia Liquid Biopsy Market & Forecast
7.2.7 Others Liquid Biopsy Market & Forecast
7.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast


8. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2016 - 2028) 
8.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
8.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
8.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
8.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast


9. Global Liquid Biopsy Market & Forecast - by End User (2016 - 2028) 
9.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
9.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
9.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
9.4 Global Liquid Biopsy - Other End Users Market & Forecast


10. Global Liquid Biopsy Market & Forecast - by Sample Type (2016 - 2028) 
10.1 Global Liquid Biopsy - Blood Sample Market & Forecast
10.2 Global Liquid Biopsy - Urine Sample Market & Forecast
10.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast


11. Liquid Biopsy Market & Forecast - Regional Analysis (2016 - 2028) 
11.1 North America Liquid Biopsy Market & Forecast
11.2 Asia Pacific Liquid Biopsy Market & Forecast
11.3 Europe Liquid Biopsy Market & Forecast
11.4 Latin America Liquid Biopsy Market & Forecast
11.5 Middle East & Africa Liquid Biopsy Market & Forecast


12. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2016 - 2028) 
12.1 North America Liquid Biopsy Market & Forecast
12.1.1 United States Liquid Biopsy Market & Forecast
12.1.2 Canada Liquid Biopsy Market & Forecast
12.2 Asia Pacific Liquid Biopsy Market & Forecast
12.2.1 South Korea Liquid Biopsy Market & Forecast
12.2.2 Japan Liquid Biopsy Market & Forecast
12.2.3 China Liquid Biopsy Market & Forecast
12.2.4 India Liquid Biopsy Market & Forecast
12.2.5 Australia Liquid Biopsy Market & Forecast
12.2.6 Rest of Asia Pacific Liquid Biopsy Market & Forecast
12.3 Europe Liquid Biopsy Market & Forecast
12.3.1 Germany Liquid Biopsy Market & Forecast
12.3.2 France Liquid Biopsy Market & Forecast
12.3.3 United Kingdom Liquid Biopsy Market & Forecast
12.3.4 Italy Liquid Biopsy Market & Forecast
12.3.5 Spain Liquid Biopsy Market & Forecast
12.3.6 Rest of Europe Liquid Biopsy Market & Forecast
12.4 Middle East & Africa Liquid Biopsy Market & Forecast
12.4.1 UAE Liquid Biopsy Market & Forecast
12.4.2 Saudi Arabia Liquid Biopsy Market & Forecast
12.4.3 Egypt Liquid Biopsy Market & Forecast
12.4.4 Rest of Middle East & Africa Liquid Biopsy Market & Forecast
12.5 Latin America Liquid Biopsy Market & Forecast


13. Liquid Biopsy Initiatives


14. Liquid Biopsy Companies Financing Details


15. Company Profiles
15.1 Personal Genome Diagnostics
15.1.1 Company Overview
15.1.2 Recent Developments / Initiatives
15.2 Guardant Health, Inc. 
15.2.1 Company Overview
15.2.2 Recent Developments / Initiatives
15.3 Pathway Genomics (Now OME CARE) 
15.3.1 Company Overview
15.3.2 Recent Developments / Initiatives
15.4 RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.) 
15.4.1 Company Overview
15.4.2 Recent Developments / Initiatives
15.5 Cardiff Oncology (Previously Trovagene, Inc.) 
15.5.1 Company Overview
15.5.2 Recent Developments / Initiatives
15.6 LungLife AI (Formerly Cynvenio Biosystems, Inc.) 
15.6.1 Company Overview
15.6.2 Recent Developments / Initiatives
15.7 Biocept, Inc. 
15.7.1 Company Overview
15.7.2 Recent Developments / Initiatives
15.8 ANGLE plc
15.8.1 Company Overview
15.8.2 Recent Developments / Initiatives
15.9 MDxHealth
15.9.1 Company Overview
15.9.2 Recent Developments / Initiatives
15.10 Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd) 
15.10.1 Company Overview
15.10.2 Recent Developments / Initiatives
15.11 Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
15.11.1 Company Overview
15.11.2 Recent Developments / Initiatives
15.12 Foundation Medicine, Inc. 
15.12.1 Company Overview
15.12.2 Recent Developments / Initiatives
15.13 Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG) 
15.13.1 Company Overview
15.13.2 Recent Developments / Initiatives
15.14 Genomic Health (Now Part of Exact Sciences Corp) 
15.14.1 Company Overview
15.14.2 Recent Developments / Initiatives
15.15 Myriad Genetics, Inc. 
15.15.1 Company Overview
15.15.2 Recent Developments / Initiatives
15.16 Thermo Fisher Scientific, Inc. 
15.16.1 Company Overview
15.16.2 Recent Developments / Initiatives
15.17 QIAGEN NV
15.17.1 Company Overview
15.17.2 Recent Developments / Initiatives
15.18 Bio-Rad Laboratories, Inc. 
15.18.1 Company Overview
15.18.2 Recent Developments / Initiatives
15.19 Menarini-Silicon Biosystems
15.19.1 Company Overview
15.19.2 Recent Developments / Initiatives
15.20 GRAIL
15.20.1 Company Overview
15.20.2 Recent Developments / Initiatives
15.21 NeoGenomics, Inc.
15.21.1 Company Overview
15.21.2 Recent Developments / Initiatives
15.22 DiaCarta, Inc. 
15.22.1 Company Overview
15.22.2 Recent Developments / Initiatives
15.23 OncoCell MDx (Now Immunis.AI) 
15.23.1 Company Overview
15.23.2 Recent Developments / Initiatives
15.24 C2i Genomics
15.24.1 Company Overview
15.24.2 Recent Developments / Initiatives
15.25 Biodesix
15.25.1 Company Overview
15.25.2 Recent Developments / Initiatives
15.26 Freenome
15.26.1 Company Overview
15.26.2 Recent Developments / Initiatives
15.27 Inivata
15.27.1 Company Overview
15.27.2 Recent Developments / Initiatives
15.28 CellMax Life
15.28.1 Company Overview
15.28.2 Recent Developments / Initiatives
15.29 Rarecyte Inc. 
15.29.1 Company Overview
15.29.2 Recent Developments / Initiatives
15.30 Saga Diagnostics
15.30.1 Company Overview
15.30.2 Recent Developments / Initiatives
15.31 Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)
15.31.1 Company Overview
15.31.2 Recent Developments / Initiatives
15.32 Lucence Diagnostics Pte Ltd
15.32.1 Company Overview
15.32.2 Recent Developments / Initiatives
15.33 Karius, Inc. 
15.33.1 Company Overview
15.33.2 Recent Developments / Initiatives
15.34 Clinical Genomics Technologies Pty Ltd (CG) 
15.34.1 Company Overview
15.34.2 Recent Developments / Initiatives
15.35 Elypta
15.35.1 Company Overview
15.35.2 Recent Developments / Initiatives


16. Global Liquid Biopsy Market - Driving Factors
16.1 Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market
16.2 Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice
16.3 Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market
16.4 New Liquid Biopsy Product Launches to Fuel Market Revenues
16.5 Government Funds for Refining Cancer Detection Drives the Liquid Biopsy Market Growth
16.6 Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market


17. Global Liquid Biopsy Market - Challenges
17.1 Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market
17.2 Liquid Biopsy Clinical Utility Challenges
17.3 Unclear Regulations on Laboratory Developed Tests (LDT) for Liquid Biopsy


List of Figures:


Figure 3-1: Global - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 3-2: Global - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028


Figure 4-1: By Circulating Biomarker - Liquid Biopsy Market Share (Percent), 2016 - 2020
Figure 4-2: By Circulating Biomarker - Forecast for Liquid Biopsy Market Share (Percent), 2021 - 2028
Figure 4-3: By Product - Liquid Biopsy Market Share (Percent), 2016 - 2020
Figure 4-4: By Product - Forecast for Liquid Biopsy Market Share (Percent), 2021 - 2028
Figure 4-5: By Application - Liquid Biopsy Market Share (Percent), 2016 - 2020
Figure 4-6: By Application - Forecast for Liquid Biopsy Market Share (Percent), 2021 - 2028
Figure 4-7: By Clinical Application - Liquid Biopsy Oncology Market Share (Percent), 2016 - 2020
Figure 4-8: By Clinical Application - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2021 - 2028
Figure 4-9: By End User - Liquid Biopsy Market Share (Percent), 2016 - 2020
Figure 4-10: By End User - Forecast for Liquid Biopsy Market Share (Percent), 2021 - 2028
Figure 4-11: By Sample Type - Liquid Biopsy Market Share (Percent), 2016 - 2020
Figure 4-12: By Sample Type - Forecast for Liquid Biopsy Market Share (Percent), 2021 - 2028


Figure 5-1: Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market (Million US$), 2016 - 2020
Figure 5-2: Global Liquid Biopsy - Forecast for Circulating Tumor Cells (CTCs) Market (Million US$), 2021 - 2028
Figure 5-3: Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market (Million US$), 2016 - 2020
Figure 5-4: Global Liquid Biopsy - Forecast for Circulating Tumor DNA (ctDNA) Market (Million US$), 2021 - 2028
Figure 5-5: Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market (Million US$), 2016 - 2020
Figure 5-6: Global Liquid Biopsy - Forecast for Cell-Free DNA (cfDNA) Market (Million US$), 2021 - 2028
Figure 5-7: Global Liquid Biopsy - Extracellular Vesicles (EVs) Market (Million US$), 2016 - 2020
Figure 5-8: Global Liquid Biopsy - Forecast for Extracellular Vesicles (EVs) Market (Million US$), 2021 - 2028
Figure 5-9: Global Liquid Biopsy - Other Circulating Biomarkers Market (Million US$), 2016 - 2020
Figure 5-10: Global Liquid Biopsy - Forecast for Other Circulating Biomarkers Market (Million US$), 2021 - 2028


Figure 6-1: Global Liquid Biopsy - Kits and Consumables Market (Million US$), 2016 - 2020
Figure 6-2: Global Liquid Biopsy - Forecast for Kits and Consumables Market (Million US$), 2021 - 2028
Figure 6-3: Global Liquid Biopsy - Instruments Market (Million US$), 2016 - 2020
Figure 6-4: Global Liquid Biopsy - Forecast for Instruments Market (Million US$), 2021 - 2028
Figure 6-5: Global Liquid Biopsy - Services Market (Million US$), 2016 - 2020
Figure 6-6: Global Liquid Biopsy - Forecast for Services Market (Million US$), 2021 - 2028


Figure 7-1: Global Liquid Biopsy - Oncology Application Market (Million US$), 2016 - 2020
Figure 7-2: Global Liquid Biopsy - Forecast for Oncology Application Market (Million US$), 2021 - 2028
Figure 7-3: Global - Lung Cancer Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 7-4: Global - Forecast for Lung Cancer Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 7-5: Global - Breast Cancer Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 7-6: Global - Forecast for Breast Cancer Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 7-7: Global - Colorectal Cancer Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 7-8: Global - Forecast for Colorectal Cancer Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 7-9: Global - Prostate Cancer Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 7-10: Global - Forecast for Prostate Cancer Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 7-11: Global - Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 7-12: Global - Forecast for Gastrointestinal Cancer Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 7-13: Global - Leukaemia Cancer Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 7-14: Global - Forecast for Leukaemia Cancer Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 7-15: Global - Others Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 7-16: Global - Forecast for Others Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 7-17: Global Liquid Biopsy - Non-Cancer Application Market (Million US$), 2016 - 2020
Figure 7-18: Global Liquid Biopsy - Forecast for Non-Cancer Application Market (Million US$), 2021 - 2028


Figure 8-1: Global Liquid Biopsy Oncology Application - Therapy Selection Market (Million US$), 2016 - 2020
Figure 8-2: Global Liquid Biopsy Oncology Application - Forecast for Therapy Selection Market (Million US$), 2021 - 2028
Figure 8-3: Global Liquid Biopsy Oncology Application - Treatment Monitoring Market (Million US$), 2016 - 2020
Figure 8-4: Global Liquid Biopsy Oncology Application - Forecast for Treatment Monitoring Market (Million US$), 2021 - 2028
Figure 8-5: Global Liquid Biopsy Oncology Application - Early Cancer Screening Market (Million US$), 2016 - 2020
Figure 8-6: Global Liquid Biopsy Oncology Application - Forecast for Early Cancer Screening Market (Million US$), 2021 - 2028
Figure 8-7: Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market (Million US$), 2016 - 2020
Figure 8-8: Global Liquid Biopsy Oncology Application - Forecast for Recurrence Monitoring Market (Million US$), 2021 - 2028


Figure 9-1: Global Liquid Biopsy - Reference Laboratories Market (Million US$), 2016 - 2020
Figure 9-2: Global Liquid Biopsy - Forecast for Reference Laboratories Market (Million US$), 2021 - 2028
Figure 9-3: Global Liquid Biopsy - Hospitals and Physician Laboratories Market (Million US$), 2016 - 2020
Figure 9-4: Global Liquid Biopsy - Forecast for Hospitals and Physician Laboratories Market (Million US$), 2021 - 2028
Figure 9-5: Global Liquid Biopsy - Academic and Research Centers Market (Million US$), 2016 - 2020
Figure 9-6: Global Liquid Biopsy - Forecast for Academic and Research Centers Market (Million US$), 2021 - 2028
Figure 9-7: Global Liquid Biopsy - Other End Users Market (Million US$), 2016 - 2020
Figure 9-8: Global Liquid Biopsy - Forecast for Other End Users Market (Million US$), 2021 - 2028


Figure 10-1: Global Liquid Biopsy - Blood Sample Market (Million US$), 2016 - 2020
Figure 10-2: Global Liquid Biopsy - Forecast for Blood Sample Market (Million US$), 2021 - 2028
Figure 10-3: Global Liquid Biopsy - Urine Sample Market (Million US$), 2016 - 2020
Figure 10-4: Global Liquid Biopsy - Forecast for Urine Sample Market (Million US$), 2021 - 2028
Figure 10-5: Global Liquid Biopsy - Other Fluids Sample Market (Million US$), 2016 - 2020
Figure 10-6: Global Liquid Biopsy - Forecast for Other Fluids Sample Market (Million US$), 2021 - 2028


Figure 11-1: North America - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 11-2: North America - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 11-3: Asia Pacific - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 11-4: Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 11-5: Europe - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 11-6: Europe - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 11-7: Latin America - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 11-8: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 11-9: Middle East & Africa - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 11-10: Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028


Figure 12-1: United States - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-2: United States - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-3: Canada - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-4: Canada - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-5: South Korea - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-6: South Korea - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-7: Japan - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-8: Japan - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-9: China - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-10: China - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-11: India - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-12: India - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-13: Australia - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-14: Australia - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-15: Rest of Asia Pacific - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-16: Rest of Asia Pacific - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-17: Germany - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-18: Germany - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-19: France - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-20: France - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-21: United Kingdom - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-22: United Kingdom - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-23: Italy - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-24: Italy - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-25: Spain - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-26: Spain - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-27: Rest of Europe - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-28: Rest of Europe - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-29: UAE - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-30: UAE - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-31: Saudi Arabia - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-32: Saudi Arabia - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-33: Egypt - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-34: Egypt - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-35: Rest of Middle East & Africa - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-36: Rest of Middle East & Africa - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028
Figure 12-37: Latin America - Liquid Biopsy Market (Million US$), 2016 - 2020
Figure 12-38: Latin America - Forecast for Liquid Biopsy Market (Million US$), 2021 - 2028


List of Tables:


Table 4-1: By Cancer Types - Liquid Biopsy Oncology Market Share (Percent), 2016 - 2020
Table 4-2: By Cancer Types - Forecast for Liquid Biopsy Oncology Market Share (Percent), 2021 - 2028
Table 4-3: By Region - Liquid Biopsy Market Share (Percent), 2016 - 2020
Table 4-4: By Region - Forecast for Liquid Biopsy Market Share (Percent), 2021 - 2028
Table 4-5: By Country - Liquid Biopsy Market Share (Percent), 2016 - 2020
Table 4-6: By Country - Forecast for Liquid Biopsy Market Share (Percent), 2021 - 2028


Table 15-1: Clearbridge BioMedics - Distributors in EMEA and APAC Regions


Note: Product cover images may vary from those shown
  • Personal Genome Diagnostics
  • Guardant Health, Inc.
  • Pathway Genomics (Now OME CARE)
  • RainDance Technologies (Acquired by Bio-Rad Laboratories, Inc.)
  • Cardiff Oncology (Previously Trovagene, Inc.)
  • LungLife AI (Formerly Cynvenio Biosystems, Inc.)
  • Biocept, Inc.
  • ANGLE plc
  • MDxHealth
  • Biolidics Limited (Formerly Clearbridge Biomedics Pte Ltd)
  • Exosome Diagnostics, Inc. (Acquired by Bio-Techne Corporation)
  • Foundation Medicine, Inc
  • Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
  • Genomic Health (Now Part of Exact Sciences Corp)
  • Myriad Genetics, Inc
  • Thermo Fisher Scientific, Inc
  • QIAGEN NV
  • Bio-Rad Laboratories, Inc
  • Menarini-Silicon Biosystems
  • GRAIL
  • NeoGenomics, Inc.
  • DiaCarta, Inc.
  • OncoCell MDx (Now Immunis.AI)
  • C2i Genomics
  • Biodesix
  • Freenome
  • Inivata
  • CellMax Life
  • Rarecyte Inc.
  • Saga Diagnostics
  • Thrive Earlier Detection Corp. (Acquired by Exact Sciences Corp.)
  • Lucence Diagnostics Pte Ltd
  • Karius, Inc.
  • Clinical Genomics Technologies Pty Ltd (CG)
  • Elypta
Note: Product cover images may vary from those shown